Amprion Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Amprion is a biotechnology research company focused on precision medicine for neurodegenerative disorders through seed amplification testing. Its SAAmplify-ɑSYN biomarker test is a qualitative laboratory-developed assay that detects pathogenic alpha-synuclein to aid the diagnosis of synucleinopathies, including Parkinson's disease, Lewy body dementia, and Alzheimer's disease with Lewy bodies variant. The company is based in San Francisco, California, and operates with a small to mid-sized team. Its customers are clinical laboratories and healthcare providers seeking diagnostic tools for neurodegenerative disorders. In 2025, Amprion announced a collaboration with Mayo Clinic Laboratories to broaden access to the SAAmplify-ɑSYN test.